{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:30:53Z","timestamp":1791192653931,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T00:00:00Z","timestamp":1374624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund (FWF)","doi-asserted-by":"crossref","award":["NFN S10704"],"award-info":[{"award-number":["NFN S10704"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund (FWF)","doi-asserted-by":"crossref","award":["S10702\/10711"],"award-info":[{"award-number":["S10702\/10711"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund (FWF)","doi-asserted-by":"crossref","award":["S10703"],"award-info":[{"award-number":["S10703"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund (FWF)","doi-asserted-by":"crossref","award":["S10701"],"award-info":[{"award-number":["S10701"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund (FWF)","doi-asserted-by":"crossref","award":["P23317-B11"],"award-info":[{"award-number":["P23317-B11"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Austrian Federal Ministries of Science and Research"},{"name":"Health [TCM and Age-Related Diseases]"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (NSFC)","doi-asserted-by":"crossref","award":["81274051"],"award-info":[{"award-number":["81274051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.bbagen.2013.06.021","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T13:01:17Z","timestamp":1372338077000},"page":"4813-4819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Honokiol: A non-adipogenic PPAR\u03b3 agonist from nature"],"prefix":"10.1016","volume":"1830","author":[{"given":"Atanas G.","family":"Atanasov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian N.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi P.","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias P.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanang","family":"Fakhrudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ladurner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Malainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vuorinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M.","family":"Noha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schwaiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Rollinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Stuppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena M.","family":"Dirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke H.","family":"Heiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2013.06.021_bb0005","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/ATVBAHA.108.179689","article-title":"Fibrates, glitazones, and peroxisome proliferator-activated receptors","volume":"30","author":"Lalloyer","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0010","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.2337\/diabetes.54.8.2460","article-title":"Therapeutic roles of peroxisome proliferator-activated receptor agonists","volume":"54","author":"Staels","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2013.06.021_bb0015","first-page":"1045","article-title":"Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance","volume":"5","author":"Patsouris","year":"2004","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.bbagen.2013.06.021_bb0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1152\/physrev.00025.2005","article-title":"Transcriptional regulation of metabolism","volume":"86","author":"Desvergne","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nm1025","article-title":"PPARs and the complex journey to obesity","volume":"10","author":"Evans","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0030","first-page":"247","article-title":"Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis","volume":"9","author":"Hansen","year":"2008","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.bbagen.2013.06.021_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00041433-199706000-00006","article-title":"Peroxisome proliferator-activated receptors, orphans with ligands and functions","volume":"8","author":"Schoonjans","year":"1997","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/bbrc.1993.1378","article-title":"PPAR\u2013RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene","volume":"192","author":"Bardot","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0045","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/417563a","article-title":"Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis","volume":"417","author":"Ge","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2013.06.021_bb0050","doi-asserted-by":"crossref","first-page":"10626","DOI":"10.1073\/pnas.93.20.10626","article-title":"The nuclear hormone receptor coactivator SRC-1 is a specific target of p300","volume":"93","author":"Yao","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0055","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bbalip.2007.02.013","article-title":"PPARs and molecular mechanisms of transrepression","volume":"1771","author":"Ricote","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2013.06.021_bb0060","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.reprotox.2008.10.001","article-title":"Review of the expression of peroxisome proliferator-activated receptors alpha (PPAR alpha), beta (PPAR beta), and gamma (PPAR gamma) in rodent and human development","volume":"27","author":"Abbott","year":"2009","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0065","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.58.4.5","article-title":"International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors","volume":"58","author":"Michalik","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0070","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1172\/JCI28003","article-title":"PPAR gamma and human metabolic disease","volume":"116","author":"Semple","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0075","doi-asserted-by":"crossref","first-page":"41626","DOI":"10.1074\/jbc.M111.257915","article-title":"N-Acetyl Farnesyl cysteine is a novel class of PPAR{gamma} ligand with partial and full agonist activity in vitro and in vivo","volume":"286","author":"Bhalla","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/138955712798995048","article-title":"Balaglitazone: a second generation peroxisome proliferator-activated receptor (PPAR) gamma (gamma) agonist","volume":"12","author":"Agrawal","year":"2012","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0085","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1124\/mol.109.062141","article-title":"Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor gamma","volume":"77","author":"Fakhrudin","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0090","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/358771a0","article-title":"Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors","volume":"358","author":"Kliewer","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2013.06.021_bb0095","doi-asserted-by":"crossref","first-page":"8772","DOI":"10.1073\/pnas.0905745107","article-title":"Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon","volume":"107","author":"Peyrin-Biroulet","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0100","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1248\/cpb.39.2024","article-title":"Isolation and characterization of phenolic compounds from magnoliae cortex produced in China","volume":"39","author":"Shoji","year":"1991","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0105","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1128\/MCB.00915-07","article-title":"NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis","volume":"27","author":"Shin","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1507\/endocrj1954.17.23","article-title":"General survey of diabetic features of yellow KK mice","volume":"17","author":"Iwatsuka","year":"1970","journal-title":"Endocrinol. Jpn."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2337\/diab.44.1.43","article-title":"Reduced expression of hexokinase II in insulin-resistant diabetes","volume":"44","author":"Braithwaite","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2013.06.021_bb0120","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/nsmb.1474","article-title":"Structural basis for the activation of PPARgamma by oxidized fatty acids","volume":"15","author":"Itoh","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0125","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10822-007-9140-0","article-title":"Pharmacophore modeling and parallel screening for PPAR ligands","volume":"21","author":"Markt","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0135","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nrm2066","article-title":"Adipocyte differentiation from the inside out","volume":"7","author":"Rosen","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/187152508785909465","article-title":"Medicinal agents in the metabolic syndrome","volume":"6","author":"Banos","year":"2008","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0145","doi-asserted-by":"crossref","first-page":"e28253","DOI":"10.1371\/journal.pone.0028253","article-title":"Molecular determinants of magnolol targeting both RXRalpha and PPARgamma","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2013.06.021_bb0150","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/np100120c","article-title":"Identification of a naturally occurring rexinoid, honokiol, that activates the retinoid X receptor","volume":"73","author":"Kotani","year":"2010","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0155","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s11418-011-0512-3","article-title":"Honokiol enhances adipocyte differentiation by potentiating insulin signaling in 3T3-L1 preadipocytes","volume":"65","author":"Choi","year":"2011","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0160","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/jpet.103.049791","article-title":"PAT5A: a partial agonist of peroxisome proliferator-activated receptor gamma is a potent antidiabetic thiazolidinedione yet weakly adipogenic","volume":"306","author":"Misra","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0165","doi-asserted-by":"crossref","first-page":"8541","DOI":"10.1021\/jm201061j","article-title":"Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulators","volume":"54","author":"Liu","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0170","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1210\/me.2008-0473","article-title":"MBX-102\/JNJ39659100, a novel peroxisome proliferator-activated receptor\u2013ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema","volume":"23","author":"Gregoire","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbagen.2013.06.021_bb0175","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/nm.2421","article-title":"Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity","volume":"17","author":"Diano","year":"2011","journal-title":"Nat. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441651300281X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441651300281X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:23:39Z","timestamp":1588958619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030441651300281X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S030441651300281X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2013.06.021","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Honokiol: A non-adipogenic PPAR\u03b3 agonist from nature","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2013.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}